Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The New England Journal of Medicine|February 16, 2022
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2024
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized TrialJennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
Arthritis and Rheumatism|December 16, 2003
Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trialDavid E Yocum, Daniel E Furst, Jeffrey L Kaine, et al.
The New England Journal of Medicine|July 17, 2024
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19Jennifer Hammond, Carla Yunis, Robert J Fountaine, et al.
The New England Journal of Medicine|April 10, 2024
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19Jennifer Hammond, Robert J Fountaine, Carla Yunis, et al.
Pediatrics|June 24, 2026
Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and OlderJacqueline Gerhart, Heidi Leister-Tebbe, Phylinda L S Chan, et al.
The Lancet. Infectious Diseases|July 17, 2025
Extended nirmatrelvir-ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trialEdward Weinstein, Roger Paredes, Annie Gardner, et al.
Pageof 2